Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company filings document material-event reporting for an Ohio-incorporated consumer products issuer with PG common stock listed on the New York Stock Exchange. The company’s recent 8-K records identify its registered common stock and a broad schedule of exchange-listed notes.
Those disclosures cover capital-structure reference points, including U.S. dollar, euro and British pound notes with maturities spanning short- and long-dated issues. The filings also provide recurring public-company identifiers, exchange listings and formal reporting details tied to P&G’s securities.
McCarthy Christine M reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Christine M. McCarthy received an award of 209 shares of Common Stock on March 10, 2026. The filing describes this as a grant or award transaction, with no cash price per share reported.
These shares are in the form of Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The total reported direct holdings after this award are 17,128.6365 shares, which include dividend equivalents granted as additional Restricted Stock Units.
Kempczinski Christopher J reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Christopher J. Kempczinski received an award of 201 shares of Common Stock as a grant under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. After this compensation-related award, his directly held stake increased to 11,251.4805 shares, including dividend-equivalent restricted stock units.
JIMENEZ JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Joseph Jimenez received a grant of 273 shares of Common Stock in the form of restricted stock units. The award was made at no cash price as part of The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents credited as additional units. After this compensation-related grant, his directly held position reported in this filing increased to 36,512.1482 shares of Common Stock, showing this is a relatively small, routine addition to an existing stake rather than a market purchase or sale.
ARNOLD CRAIG reported acquisition or exercise transactions in this Form 4 filing.
Procter & Gamble director Craig Arnold received a grant of 161 shares of Common Stock through Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The award, which includes dividend equivalents in the form of additional Restricted Stock Units, increased his directly held position to 2,586.0624 shares.
PROCTER & GAMBLE Co executive Francisco Ma. Fatima, CEO of Baby, Fem & Family Care, reported multiple stock moves. On February 27, 2026, she completed open-market sales totaling 5,549 shares of common stock at prices around $165.29 to $165.32, leaving 1,028.739 directly held shares.
She also received a grant of 57.0033 Restricted Stock Units on February 17, 2026, bringing her direct RSU holdings to 888.7607 units. Footnotes explain these RSUs include dividend equivalents that will deliver in shares at retirement or as deferred compensation. Additional indirect common stock holdings are reported through retirement plans, a spouse, and a SLAT trust.
PROCTER & GAMBLE Co executive Francisco Ma. Fatima, CEO of Baby, Fem & Family Care, reported multiple stock moves. On February 27, 2026, she completed open-market sales totaling 5,549 shares of common stock at prices around $165.29 to $165.32, leaving 1,028.739 directly held shares.
She also received a grant of 57.0033 Restricted Stock Units on February 17, 2026, bringing her direct RSU holdings to 888.7607 units. Footnotes explain these RSUs include dividend equivalents that will deliver in shares at retirement or as deferred compensation. Additional indirect common stock holdings are reported through retirement plans, a spouse, and a SLAT trust.
PROCTER & GAMBLE Co executive Susan Street Whaley reported both a stock sale and an equity award. On February 19, 2026, she completed an open-market sale of 1,809 shares of common stock at an average price of $159.4551 per share.
After this sale, her directly held common stock position was 30,215.0293 shares. She also had 6,589.6417 shares held indirectly through a retirement plan trustee. On February 17, 2026, she acquired 11.485 restricted stock units at no cost, increasing her RSU balance to 65.1290 units, which are scheduled to settle in Procter & Gamble common stock, generally in connection with retirement.
Morgan Stanley Smith Barney LLC files a Form 144 reporting proposed sales of Procter & Gamble common stock. The notice lists 1,400 shares tied to a Restricted Stock Unit Award dated 10/01/2021 and 1,493 shares from a Performance Stock Program Award dated 08/19/2024.
Procter & Gamble's Chief Research, Development & Innovation Officer, Aguilar Moses Victor Javier, exercised stock options and sold shares on February 13, 2026. He exercised 15,169 stock options at an exercise price of $91.07 per share, receiving the same number of common shares.
On the same day, he sold 15,169 common shares in an open-market transaction at a weighted average price of $162.2789 per share, within a price range of $162.26 to $162.311. Following these transactions, he held 44,735.4826 common shares directly, plus additional indirect holdings through a retirement plan and an international stock ownership plan.
Procter & Gamble’s Chief Human Resources Officer, Purushothaman Balaji, reported an option exercise and share sale on February 11, 2026. He exercised a stock option for 12,827 shares of common stock at an exercise price of $91.07 per share.
On the same day, he sold 12,827 common shares in an open-market transaction at a weighted average price of $160.3093 per share, as disclosed in the footnote. Following these transactions, he held 12,638.8004 shares directly and 5,223.363 shares indirectly through a retirement plan trustee.
Procter & Gamble executive chair Jon R. Moeller, who also serves as a director, reported option exercises and share sales in February 2026. On February 11, he exercised options for 11,036 common shares at $113.23 and sold 11,036 shares at $160. On February 12, he exercised options for 162,232 shares at $113.23 and sold 162,232 shares at a weighted average price of $162.4486. After these transactions, he directly holds 319,384.99 common shares, plus indirect holdings of 25,001.0511 shares through retirement plan trustees and 35,421.5707 shares held by his spouse.